U.S. Markets closed

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0200-0.0200 (-1.92%)
At close: 4:00PM EDT

1.0200 0.00 (0.00%)
After hours: 4:02PM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.0400
Open1.0500
Bid1.0100 x 28000
Ask1.0300 x 2200
Day's Range1.0100 - 1.0600
52 Week Range0.4000 - 1.9700
Volume543,049
Avg. Volume3,027,149
Market Cap56.585M
Beta (5Y Monthly)1.17
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance
    PR Newswire

    Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to Advance Trials with COVID-19 Compliance

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it has filed an amendment to its Mino-Lok phase 3 protocol. This amendment was designed to allow for more efficient follow-up and record-keeping of required clinical trial documentation given COVID-19 restrictions. With personal visits having been severely restricted, Citius issued instructions in the form of file notes to sites in April and has now formalized these instructions. The FDA released guidance on conduct of clinical trials of medical products during COVID-19 in March 2020, updated in July 2020.

  • Citius Pharmaceuticals to Present at H.C. Wainwright Virtual 22nd Annual Global Investment Conference
    PR Newswire

    Citius Pharmaceuticals to Present at H.C. Wainwright Virtual 22nd Annual Global Investment Conference

    Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that its management is scheduled to present at the H.C. Wainwright 22nd Annual Global Investment Conference to be held virtually on September 14-16, 2020. Leonard Mazur, Chairman of Citius, will present on Tuesday, September 15, at 11:00 a.m. Eastern Time where he will deliver a corporate overview of the Company.

  • ACCESSWIRE

    LD Micro: 360 Companies--Set to Present this Week.

    LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.